Proof-of-principle" that cell replacement therapy works for neurodegeneration has been reported, but only using donor cells collected from fetal brain tissue obtained from surgical terminations of pregnancy. Surgical terminations of pregnancy represent an increasingly limited supply of donor cells due to the tendency towards performing medical termination in much of Europe. This imposes a severe constraint on further experimental and clinical cell transplantation research. Therefore, we explore here the feasibility of using medical termination tissue as a donor source. Products of conception were retrieved from surgical terminations over the last 7 years and from medical terminations over the last 2.5 years. The number of collections that yielded fetal tissue, viable brain tissue, and identifiable brain regions (ganglionic eminence, ventral mesencephalon, and neocortex) were recorded. We studied cell viability, cell physiological properties, and differentiation potential both in vitro and following transplantation into the central nervous system of rodent models of neurodegenerative disease. Within equivalent periods, we were able to collect substantially greater numbers of fetal remains from medical than from surgical terminations of pregnancy, and the medical terminations yielded a much higher proportion of identifiable and dissectible brain tissue. Furthermore, we demonstrate that harvested cells retain the capacity to differentiate into neurons with characteristics appropriate to the region from which they are dissected. We show that, contrary to widespread assumption, medical termination of pregnancy-derived fetal brain cells represent a feasible and more readily available source of human fetal tissue for experimental cell transplantation with the potential for use in future clinical trials in human neurodegenerative disease. 503 504 KELLY ET AL.
INTRODUCTION
Empirically, the most successful transplants are taken from the developing fetal brain close to the time of birth of the specific populations of neurons to be transplanted Cell replacement therapy involves the transplantation of human fetal neuroblasts, obtained from elective ter- (18) . At this stage the fate of the neurons is determined, but they retain the developmental plasticity required to minations of pregnancy, into the brains of patients with neurodegenerative diseases such as Parkinson's (PD) integrate into the adult host environment. As a consequence, tissue for transplantation must be harvested and Huntington's disease (HD) (17, 27) . Following transplantation, implanted neuroblasts can mature, innervate within a specific gestational time window, and from the precise region in the developing (fetal) brain that con-the surrounding neuropil, and contribute to the repair of circuitry that has been damaged as a result of the tains the cells lost in the disease process. For example, the dopamine containing neurons of the ventral mesen-degeneration. Several clinical trials for both PD and HD have demonstrated proof-of-principle that cell replace-cephalon (VM), and the medium spiny neurons (MSNs) developing within the fetal ganglionic eminence (GE-ment therapy can provide significant alleviation of symptoms in both conditions (1, 19, 22) . putative striatum), for PD and HD, respectively, are born in the developing human brain towards the end of the ranged in age from 6 to 12 weeks pc, assessed by ultrasound measurements and confirmed using fetal morpho-first trimester [VM between 4 and 6 weeks (30) and GE between 6 and 9 weeks postconception (pc), respectively metric data upon termination (8, 14) . (26) ].
Surgical Termination of Pregnancy To date, successful clinical trials have utilized fetal tissue from surgical terminations of pregnancy (STOP).
Tissue was collected via low-pressure aspiration using an Ipas manual vacuum aspirator and cannulae (Dur-We have been collecting tissue from STOP for cell research and replacement therapies since 1997 using low-bin Clinic Sales, Middlesex, UK), with the aid of transvaginal ultrasound. Following extraction, the products of pressure transvaginal aspiration, with research ethical committee approvals and with informed maternal con-conception were discharged into 50-ml centrifuge tubes containing phosphate-buffered saline (PBS) supplemented sent (26) . However, STOP tissue of suitable quality is in limited supply due to several factors. Routine high-with glucose (0.6%) and heparin (5 µg/ml). Collected material was transferred to a petri dish for inspection, pressure aspiration of fetal material does not yield identifiable brain tissue, so that successful collection re-and fetal parts transferred to a labeled 50-ml centrifuge tube containing commercial hibernation medium (Hiber-quires engagement of an interested surgeon willing to gain experience with low-pressure aspiration for collec-nate E, Invitrogen, Strathclyde, UK), and transported on ice to the laboratory. tion of tissues for research use. Moreover, even low-pressure aspiration results in substantial tissue fragmentation, Medical Termination of Pregnancy variable tissue quality, and difficulty in standardization of collection and dissection procedures. The pressure on Mifepristone (200 mg) was administered orally and the patient admitted to the gynecology ward 36-48 h supply has been compounded by the requirement for multiple fetal donors per patient in order to achieve sat-later, at which time 800 µg misoprostol was self-administered transvaginally. Following expulsion of the prod-isfactory cell numbers for some applications such as PD neural transplantation (18) , and more recently by the ucts of conception into a disposable cardboard receptacle, fetal material was inspected by the nursing staff, move throughout Europe towards replacing STOP with medical termination of pregnancy (MTOP) (5, 7) . MTOP was promptly transferred to a sterile 500-ml pot containing Hibernate E, and was stored at 4°C (usually for up is induced by administration of prostaglandin and antiprogesterone drugs over a 48-h period, and the fetus is to 3 h but for a maximum of 12 h) before being transported on ice. The time at which the products of concep-usually passed during the following 8-12 h. In our own center, this has resulted in STOP tissue becoming an tion were passed were recorded. extremely scarce resource over the last 2-3 years.
Assessment of Gestational Age Collection from spontaneous pregnancy loss has already been shown to be unsuitable for use in human
The age of the fetus was estimated using three methods: i) ultrasound in the clinic, ii) crown-rump length transplantation (3, 11) , and the use of MTOP material was not previously pursued due to the assumption that (CRL) of the tissue in the laboratory, and iii) when the fetal remains were fragmented (more common in STOP the pharmacological agents used to induce termination and the unspecified period of fetal death prior to expul-products), CRL was estimated using a formula based on measurement of fetal limbs and other body parts (8,12). sion would adversely affect the viability of the collected tissues. However, on the basis of experimental analyses, Dissection and Preparation of Human CNS Tissue these assumptions can be challenged, and here we demonstrate good viability of MTOP-derived fetal brain tis-Tissues of interest (VM, GE, and cortex) were dissected and tissue pieces were stored overnight in Hiber-sue in experimental cell transplantation. These new data pave the way for detailed preclinical functional screen-nate E at 4°C for processing the following day. The small number of embryos that were collected on the day ing to assess the suitability of MTOP-derived fetal cells for clinical neural transplantation studies.
following termination were stored as whole embryos in Hibernate E overnight at 4°C and dissected and pro-MATERIALS AND METHODS cessed the following morning. Human fetal tissue was collected following the guide-Preparation of Cell Suspension lines of the Polkinghorne (23) and Department of Health (6) 
reports and with Bro Taf Local Research Ethics
Dissected tissue pieces were incubated in 200 µl of either TrypLE express (Invitrogen, Paisley, UK) or 0.1% Committee approval. Full consent was obtained from the maternal donor, following consent for the termination, bovine trypsin (Worthington, UK) for 20 min at 37°C, after which either benzonase (Merck, UK, 1:10,000) or as part of the MRC-sponsored, South Wales initiative for transplantation (SWIFT) program. Fetal tissue DNAase (Sigma, UK, 0.01%) was added, and tissue in-cubated for a further 5 min at 37°C. VM tissue was then sensitization (for the GE grafts) (16) , or by daily injections of cyclosporine (10 mg/kg, IP) commencing the placed in 200 µl of fresh DNAase for trituration. GE and cortical tissue were washed twice with Dulbecco's day before transplantation until the day of sacrifice (VM grafted animals), depending on the availability of pre-modified Eagle's medium (DMEM/F-12, supplemented with 1% PSF antibiotic-antimycotic), and then collected pared host animals at the time of tissue collection. For neonatal inoculation host animals were inoculated IP by centrifugation at 100 × g for 3 min. The tissue was resuspended in 200 µl DMEM/F12, and then triturated with human fetal CNS cells on the day of birth. Upon reaching adulthood (220-250 g), rats received unilateral to produce a single cell suspension.
quinolinic acid lesions of the neostriatum (standard Assessment of Cell Viability model of HD; n = 6), prior to receiving intracerebral transplants of GE cells by stereotaxic injection into the Cell suspensions from each region of interest were counted in a hemocytometer using trypan blue exclu-neostriatum at 10 weeks of age. Rats receiving VM grafts (n = 4) were "hemiparkinsonian," having been sion. The proportions of live and dead cells were recorded and viability expressed as the percentage of live unilaterally lesioned using the neurotoxin 6-OHDA, to induce >95% dopamine depletion on one side of the cells in the suspension (21). Statistical analysis was carried out with GenStat statistical software. Mean compar-brain. VM graft tissues were implanted into the dopamine-depleted striatum on the lesioned side of the brain. ison was performed using a t-test.
To assess differentiation potential, dissociated cells Transplantation were plated onto 13-mm, poly-L-lysine-coated coverslips (0.1 mg/ml in distilled H 2 O) at a density of 1 × 10 5
Dissociated suspensions of VM cells were resuspended in 0.01% DNAase in DMEM/F-12 at 300,000 cells/2 µl. cells/well. Cells were placed in the center of the coverslip in 30 µl of differentiation medium (standard me-GE cells were resuspended at 500,000 cells/2 µl. Rats were anesthetised with gaseous 1.5-3% isoflur-dium plus 1% fetal calf serum and 2% B27) and allowed to differentiate for either 3 days (VM cells) or 7 days ane in a 2:1 O 2 /NO mixture, mounted in a Kopf model 900 stereotaxic frame. All animals received 2 µl of cell (GE cells), and fed by replacing half the medium with fresh medium every 3 days. Cells were then washed us-suspension injected via a 10-µl glass microsyringe targeted at the right dorsal striatum, coordinates: anterior ing PBS and prepared for immunocytochemistry by fixation with 4% paraformaldehyde in 0.1 M PBS for 20 in front of bregma, AP = +0.6 mm; lateral to the midline, L = −2.6 mm; vertical below dura, V = −5.5 and −4.5 min. For calcium imaging the cells were maintained in differentiation media for up to 24 days. mm (1 µl at each depth); with the nose bar set −2.3 mm below the interaural line. Graft tissue was injected over Indirect fluorescent immunocytochemistry was performed using standard protocols (15) with primary anti-2 min, with a further 3 min allowed for diffusion before the needle was slowly withdrawn, the wound cleaned bodies directed against β-III tubulin (1:1000, Sigma), glial fibrillary acidic protein (GFAP, 1:1000, DAKO), and sutured, and the animal allowed to recover. All animals received a 5-ml SC injection of 0.18% sodium dopamine-and cAMP-regulated neuronal phosphoprotein (DARPP-32, 1:1000, Chemicon) and the dopamine chloride with 4% glucose (Aqupharm, Dunnington, York) to avoid dehydration. Paracetamol analgesia was marker tyrosine hydroxylase (TH, 1:1000, Chemicon), and appropriate fluorescent-labeled secondary antibod-administered via the water supply for 2 days following operation. ies. Fluorescent staining was visualized on a Leica DRMB microscope, and cell counts performed at 400× magnifi- Tissue Collection based on HuNu staining and determined using the Olympus CASTgrid stereology system on a 1:12 series. The Table 1 highlights the numbers of cases that were analyzed and identifies the differences between STOP fractionator method was used that samples a fraction of the total cells (i.e., the fraction of the area samples, the and MTOP tissue collections in relation to the number of useable tissues harvested from the two sources. Of fraction of sections stained, and the ratio between the section thickness and the dissector from which they the 600 cases consented, 17.6% STOP and 22% MTOP withdrew, either from the termination itself (in most were counted) (29) . Graft volume was calculated for each experimental group. cases) or from consent to donation. There were 13.7% MTOP donations lost as a result of the hospital protocol Calcium Imaging in which patients under 7 weeks pc were allowed home to complete the procedure if expulsion had not taken Cells were loaded with 6 µM fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR, USA) diluted in place on the ward during the course of the day. A small percentage of samples were lost at collection (0.8% and normal DMEM/F-12, for 30 min at 37°C. Cells were placed in a perfusion chamber mounted upon an Olym-10% STOP and MTOP, respectively) for a variety of less common reasons, including: nonexpulsion of the fe-pus IX71inverted microscope equipped with a Cairn monochromator-based fluorescence system (Cairn In-tus requiring emergency surgery; failure in labeling and quality control; and transportation difficulties. There struments, Faversham, Kent, UK) and were continuously superfused with a solution containing in (mM) 135 were 9.3% STOP and 29.6% MTOP samples estimated on collection to be outside the inclusion age range, NaCl, 5 KCl, 1.25 CaCl 2 , 1.2 MgCl 2 , 5 HEPES, 10 glucose, pH 7.4. Fura-2 was alternately excited at 340 and which was less than 10 weeks pc, and so were not taken for subsequent analyses. 380 nm. Images at 510 nm were acquired at 0.2 Hz by a slow-scan CCD camera (Kinetic Imaging Ltd, Notting-Of the samples collected, 43% STOP and 87.5% MTOP contained identifiable fetal parts from which ham, Notts UK). Following background subtraction, emission ratios (340/380) were calculated off-line using measurements could be taken. The age of the fetus was estimated independently, based on the Evtouchenko the Andor IQ 1.3 software package (Andor Technology, Belfast, UK). γ-Aminobutyric acid (GABA) (50 µM), equation (8), which was found to correlate closely with the age as estimated from ultrasound measurement in 50 µM kainate, 50 µM α-amino-3-hydroxyl-5-methyl-4isoxazole-propionate (AMPA), 50 µM N-methyl-D-aspar-vivo (r = 0.910, df = 126, p < 0.001). This is directly comparable to the correlation, r = 0.875, previously re-tic acid (NMDA), and 100 µM L-glutamic acid (all Sigma-Aldrich, Poole, UK) were rapidly (20 ms solution ported for STOP (26) . A substantially greater proportion of MTOPs yielded exchange) applied locally to the cells using gravitydriven perfusion through a multibarrel motorized solu-identifiable CNS tissue than did STOPs (94% MTOP compared to 39.6% STOP). Furthermore, in most tion exchanger (Bio Logic Rapid Solution Changer RSC-100; Molecular Kinetics, Pullman, WA, USA). A MTOP, the CNS tissue included brain, whereas a large proportion of the STOP yielded spinal cord with no depolarizing solution (in mM) 90 NaCl, 50 KCl, 1.25 CaCl 2 , 1.2 MgCl 2 , 5 HEPES, 10 glucose (pH 7.4) was identifiable brain tissue. This is likely to be related to the greater fragmentation seen in STOP. Specifically, used to determine neuronal excitability.
STOP samples yielded fewer than 5% (5/134) intact fe-RESULTS tuses, with most samples being significantly fragmented. By contrast, the fetus was entirely intact and in some The SWIFT program commenced in October 2003 and by the end of the period of study in March 2009, cases still within the amniotic sac in more than 90% (114/120) of MTOP. As a consequence, we were able 300 patients undergoing STOP consented to donate embryos to the program. However, since 2007, in Cardiff accurately to dissect cortex, VM, and GE from the majority of cases (see Table 1 ). Figure 1 presents the same as in the rest of the UK, the number of early terminations by STOP has declined markedly. Both the numbers data, expressed as a percentage of total MTOP or STOP consented in order to illustrate the ultimate yield of spe-and the proportion of early terminations by MTOP have cific brain regions of interest from the two TOP meth-from the GE-expressed DARPP-32 as a marker of MSNs (Fig. 3B ). The percentage of total cells that are ods, indicating the much higher yields derived from MTOP compared to STOP.
DARPP-32 positive in cultures is in the range of 60-75%, which represents 75-90% of all neurons from pri-Cell Viability mary WGE tissue in the range of 20-30 mm CRL. This is comparable to what we have reported previously from The utility of the tissue, whether for research or therapy, depends on not only supply but also the viability STOP-derived GE tissues. In the case of VM tissue the number of TH-positive neurons from each VM was cal-of the tissue obtained. Cell viability was assessed in all dissociated CNS tissues by trypan blue exclusion. Over-culated according to the age of the tissue piece. It was found that the number of TH neurons ranged from all, the viability of MTOP neurons was somewhat lower than that derived for STOP [means ± SEM, 75.73 ± 50,000 to 200,000 cells per VM, which is in accordance to previously reported studies using STOP-derived tis-1.24% vs. 85.28 ± 0.89%, respectively, t(174) = 5.399, p < 0.0001] (Fig. 2) . Previous experience has indicated sue. Secondly, we have used calcium imaging as a measure of neuronal differentiation and health, and find that an initial trypan blue exclusion higher than 80% [(22) and our unpublished results] results in good cell comparable profiles of functional cellular activity from the two tissue sources ( Figs. 4 and 5) . Specifically, at viability both in vitro and in vivo. Forty-nine percent of MTOP samples and 85% of STOP samples exceeded 24 days in vitro (DIV) cells derived from both MTOP ( Fig. 4A ) and STOP (Fig. 4B) responded to the nonse-this criterion, but the lower proportion of viable samples from MTOP was markedly offset by the much higher lective depolarizing stimulus of 50 mM extracellular KCl (high K + 1 with a rise in intracellular calcium con-rate of retrieval of brain areas of interest (e.g., 58/103 VM from MTOP vs. only 9/22 VM from STOP, from a centration ([Ca 2+ ] i ). The mean rises in [Ca 2+ ] i in the cell populations derived from MTOP and STOP were almost total of 300 initial consents in each case).
identical at around 30% above baseline (Fig. 4C) . The Characterization of MTOP Tissue mean increases in [Ca 2+ ] i that were evoked in the two populations by NMDA, GABA, AMPA, kainite, and In addition to trypan blue evaluation of viability of the freshly prepared cells, we evaluated the long-term glutamate were, again, almost indistinguishable (Fig.  4C) , with NMDA evoking the most robust rises in both viability of MTOP tissue for survival and differentiation by three additional criteria ( Figs. 3-5 ). First, MTOP-cases ( Fig. 4A, B, C) . Furthermore, after 15 min of recording, and following five further applications of ago-derived tissue was seen to differentiate into appropriate populations of neurons when cultured in vitro. In partic-nists, the responses to a subsequent depolarizing stimulus (high K + 2) evoked increases in [Ca 2+ ] i , which were ular, cultures derived from VM expressed TH, a marker of surviving dopamine neurons (Fig. 3A) and tissue not significantly diminished from those evoked by the Figure 2 . The viability of the tissue (one data point per fetus) was assessed using a trypan blue exclusion assay. The trend line shows the proportion of tissue with viability of 80% and above; this is the minimum viability currently accepted for use in clinical transplantation paradigms. For MTOP tissue 58% were above the 80% cut-off whereas for STOP tissue the percentage is much higher at 82%. first depolarizing stimulus (Figs. 4C, 5 ). This indicates mean graft volume was 0.52 mm 3 in the case of GEgrafted tissue (STOP graft volume mean = 0.69 mm 3 ) that the smaller responses seen upon application of agonists were not a result of any type of experimentally and 0.68 mm 3 in VM tissue grafts. However, the number of mature cells within the graft was somewhat different induced, time-dependent dysregulation in calcium homeostasis per se. The cell-by-cell analyses shown in Fig- for the two tissue sources with a mean of 16 cells/mm 3 DARPP-32-positive cells in the GE grafts compared to ure 5, which individually plot the responses evoked by the first depolarizing stimulus against the responses 7173cells/mm 3 for VM grafts. The low number of mature DARPP-32-positive cells in the GE grafts is most evoked by each individual agonist (and second depolarizing stimulus) of each cell, indicate that MTOP and likely due to short survival time, as it has been shown previously that such grafts require long time points in STOP essentially respond similarly to this range of agonists. Thus, the regression lines of the increases in vivo for full maturation to take place. [Ca 2+ ] i evoked by high K + 1 versus high K + 2, GABA, DISCUSSION AMPA, kainite, and L-glutamate are not significantly different from each other.
The shift from STOP to MTOP in recent years has imposed severe limitations on STOP as a source of tis-Thirdly, both VM and GE cell suspensions survived transplantation into the relevant animal lesion models, sue for both experimental and clinical studies of cell replacement therapy in CNS neurodegeneration. Contrary yielding large healthy grafts in all animals, with DARPP-32-positive ( Fig. 3C ) or TH-positive neurons (Fig. 3D) , to presupposition, we have here identified MTOP tissue as a viable source of human fetal cells for transplanta-respectively, directly comparable to previous reports of human fetal xenografts derived from STOP (15). The tion studies in neurodegenerative disorders such as PD and HD. The process of a MTOP is undertaken over a but implantation of unwanted tissues can have detrimental consequences (10,20). 48-h period, raising the possibility that the fetus could die at any time during that period. Thus, the concern that A crucial requirement of transplanted cells is that they are able to differentiate into the precise phenotype the CNS cells could be subject to a prolonged period of anoxia, rendering them nonviable for transplantation lost to the disease process. We show here for both VM and GE tissues that this can be achieved in vitro. The purposes, is fully plausible. Although a proportion of MTOP collections do indeed show lower viability than number of region specific neurons (TH and DARPP-32) generated from respective brain regions was comparable STOP cells, the vast majority were over 50% viable, and 58% were in the acceptable range (≥80% viability). In to that previously reported for STOP-derived tissue (4, 14) . Where both STOP and MTOP GE tissues were di-addition, it may be that a broader viability range proves to be acceptable, and experimental studies are ongoing rectly compared by calcium imaging, it was found that the majority of the neurons responded to all of the ago-to assess this question. Importantly, the greater variance in viability was more than off-set by the substantially nists used, a good indicator that they are functional neurons. NMDA, AMPA, kainite, and L-glutamate are all greater number of MTOP cases that could be collected over a given period of time in addition to the increased linked with striatal neuron function. The remarkable similarities in the responsiveness of MTOP and STOP number of intact brain retrievals from the MTOP cases (allowing easy identification of particular brain regions).
neurons suggest that neuroblasts derived from both sources survived the procurement process equally well This is of importance because not only is the accuracy of dissection an imperative for a successful transplant, and were able to develop into mature and functionally active neurons. Of particular note are the responses to responses over time in vitro, which should give insight into such questions in the near future. GABA. It is well documented that fetal, in contrast to adult, central neurons respond to GABA by depolariz-Following transplantation into the appropriate animal models, we also see evidence of differentiation appro-ing. This so-called fetal excitatory response of GABA A receptor activation is due to the fact that the equilibrium priate to the area from which the donor tissue was derived. Due to the scarcity of useable STOP tissue in re-potential of chloride (the permeant ion of GABA A receptor channels) of fetal neurons is more positive than the cent times, these grafts have been compared to grafts of STOP-derived striatal tissue performed in this laboratory fetal resting membrane potential (2) . That both MTOP and STOP cells respond to GABA by increasing [Ca 2+ ] i using identical conditions (26) or previously published data (4, 13, 14, 28) . Although a direct comparison would demonstrates that GABA evokes a depolarization of a magnitude sufficient to cause voltage-activated calcium have been more satisfactory, the paucity of available STOP tissue is likely to be a continuing situation, and influx, and indicates that both MTOP-and STOP-derived cells in vitro still express a fetal phenotype, even after indeed is the rationale for this study in the first place. The low numbers of DARPP-32-positive cells are gener-24 DIV. The responses to NMDA are interesting in that MTOP cells demonstrate a slightly larger population ally what is found at this survival time point and it is likely that longer periods posttransplantation are needed than STOP cells, which are clearly excitable (in that they respond to high K + 1) but do not respond robustly to allow full maturation of GE grafts.
We have shown here that MTOP-derived tissue is a to NMDA ( Fig. 5, upper central panel) . Currently, we have no explanation for this slight difference, but be-viable source of cells for experimental transplantation studies in HD and PD. The use of such tissue overcomes cause the regression lines (MTOP vs. STOP) are identical if these particular cells are excluded from the analy-the logistical issues associated with the present and future use of STOP-derived tissue. The greater spread in sis, it appears that there is a small subpopulation of cells (ca. 10%) from MTOP that are not present in STOP the viability of the MTOP-derived tissue is overcome by the greater supply of this tissue. Previously, we have cells; whether this subpopulation is selectively ablated in the STOP preparation or whether it is an artifact of reported on infectious data collected from STOP tissue (9) and similar data collection is now ongoing for the MTOP procedure is currently a matter of conjecture. However, work is ongoing to characterize further these MTOP tissue with a view to this tissue being used for 
